Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy
- 15 February 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (7) , 521-523
- https://doi.org/10.1016/0002-9149(90)90824-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patientsJournal of the American College of Cardiology, 1984
- Quantitative determination of coenzyme Q10 in human blood for clinical studiesAnalytical Biochemistry, 1984
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Factors influencing the one-year mortality of dilated cardiomyopathyThe American Journal of Cardiology, 1984
- Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activityJournal of the American College of Cardiology, 1983
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Determinants of clinical response and survival in patients with congestive heart failure treated with captoprilAmerican Heart Journal, 1982
- Results of long-term vasodilator therapy in patients with refractory congestive heart failure.Circulation, 1981
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Left ventricular ejection time index in manJournal of Applied Physiology, 1963